FR2710062B1 - Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant. - Google Patents

Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant.

Info

Publication number
FR2710062B1
FR2710062B1 FR9311089A FR9311089A FR2710062B1 FR 2710062 B1 FR2710062 B1 FR 2710062B1 FR 9311089 A FR9311089 A FR 9311089A FR 9311089 A FR9311089 A FR 9311089A FR 2710062 B1 FR2710062 B1 FR 2710062B1
Authority
FR
France
Prior art keywords
benzothiadiazine
dihydro
dioxide
preparation
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9311089A
Other languages
English (en)
Other versions
FR2710062A1 (fr
Inventor
Patrick Jimonet
Serge Mignani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9311089A priority Critical patent/FR2710062B1/fr
Priority to ZA946930A priority patent/ZA946930B/xx
Priority to JP7509020A priority patent/JPH09502711A/ja
Priority to EP94926976A priority patent/EP0719262A1/fr
Priority to IL11094094A priority patent/IL110940A0/xx
Priority to PCT/FR1994/001069 priority patent/WO1995007899A1/fr
Priority to AU76601/94A priority patent/AU7660194A/en
Publication of FR2710062A1 publication Critical patent/FR2710062A1/fr
Application granted granted Critical
Publication of FR2710062B1 publication Critical patent/FR2710062B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9311089A 1993-09-17 1993-09-17 Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant. Expired - Fee Related FR2710062B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9311089A FR2710062B1 (fr) 1993-09-17 1993-09-17 Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant.
ZA946930A ZA946930B (en) 1993-09-17 1994-09-08 Derivatives of 3 4-dihydro-2h-1 2 4-benzothiadiazine 1 1-dioxide-3-carboxylic acid their preparations and medications containing them
EP94926976A EP0719262A1 (fr) 1993-09-17 1994-09-12 Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant
IL11094094A IL110940A0 (en) 1993-09-17 1994-09-12 Derivatives of 3,4-dihydro-2h-1, 2,4-benzothiadiazine 1,1-dioxide-3-carboxylic acid, their preparation and medications containing them
JP7509020A JPH09502711A (ja) 1993-09-17 1994-09-12 ３，４−ジヒドロ−２ｈ−１，２，４−ベンゾチアジアジン１，１−ジオキシド−３−カルボン酸の誘導体、それらの製造及びそれらを含む薬剤
PCT/FR1994/001069 WO1995007899A1 (fr) 1993-09-17 1994-09-12 Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant
AU76601/94A AU7660194A (en) 1993-09-17 1994-09-12 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxide-3-carboxylic acid derivatives, their preparation and drugs containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9311089A FR2710062B1 (fr) 1993-09-17 1993-09-17 Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant.

Publications (2)

Publication Number Publication Date
FR2710062A1 FR2710062A1 (fr) 1995-03-24
FR2710062B1 true FR2710062B1 (fr) 1995-12-01

Family

ID=9450965

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9311089A Expired - Fee Related FR2710062B1 (fr) 1993-09-17 1993-09-17 Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant.

Country Status (7)

Country Link
EP (1) EP0719262A1 (fr)
JP (1) JPH09502711A (fr)
AU (1) AU7660194A (fr)
FR (1) FR2710062B1 (fr)
IL (1) IL110940A0 (fr)
WO (1) WO1995007899A1 (fr)
ZA (1) ZA946930B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012185A1 (fr) * 1996-09-17 1998-03-26 The Regents Of The University Of California Derives de benzothiadiazide et leur utilisation en tant que modulateurs positifs allosteriques du recepteur ampa
FR2801587B1 (fr) * 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889851A (en) * 1986-11-21 1989-12-26 Fujisawa Pharmaceutical Co, Ltd. Benzothiadiazine compounds, and pharmaceutical composition comprising the same
CA2130096A1 (fr) * 1992-04-15 1993-10-28 Jean-Claude Aloup Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant

Also Published As

Publication number Publication date
FR2710062A1 (fr) 1995-03-24
IL110940A0 (en) 1994-11-28
ZA946930B (en) 1995-04-12
AU7660194A (en) 1995-04-03
JPH09502711A (ja) 1997-03-18
EP0719262A1 (fr) 1996-07-03
WO1995007899A1 (fr) 1995-03-23

Similar Documents

Publication Publication Date Title
FR2711993B1 (fr) Médicaments contenant des dérivés de 7H-imidazol[1,2-a]pyrazine-8-one, les nouveaux composés et leur préparation.
FR2708606B1 (fr) Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
OA08647A (fr) Dérivés d'imidazole, procédés pour leur préparation et composition pharmaceutique les contenant.
DZ2887A1 (fr) Dérivés d'azétidine, leur préparation et les médicaments les contenant.
FR2700167B1 (fr) Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant.
OA09441A (fr) "Procédés de préparation de ptéridin-4(3H)-ones, et de compositions médicamenteuses les contenant".
OA09190A (fr) "Procédés de préparation de dérivés d'acides benzocycloalcényl dihydroxy alcanoïques et de médicaments les contenant".
OA09238A (fr) Dérivés d'isoindolinone, leurs procédés de préparation et les médicaments les contenant.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
FR2607502B1 (fr) Derives de l'imidazole, leur preparation et compositions medicamenteuses les contenant
FR2717811B1 (fr) Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant.
FI944854A0 (fi) 3,4-dihydro-2H-1,2,4-bentsotiadiatsin-1,1-dioksidi-3-karboksyylihappojohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
OA08957A (fr) Dérivés d'alcadiènes, leurs préparations, les médicaments les contenant et produits intermédiaires
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
FR2712289B1 (fr) Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
OA09439A (fr) "Nouveaux dérivés benzoxazolinoniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent".
PT90816A (pt) Processo para a preparacao de composicoes farmaceuticas contendo analogos de 2',5'-oligoadenilato
FR2710062B1 (fr) Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant.
FR2692581B1 (fr) Nouveaux dérivés peptidiques à activité antagoniste de la bradykinine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2699920B1 (fr) Dérivés d'imidazo [2,1-b] benzothiazole-3-acétamide, leur préparation et leur application en thérapeutique.
FR2701952B1 (fr) Nouveaux dérivés cyclopeptidiques de l'angiopeptine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2696457B1 (fr) Dérivés de 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde, leur préparation et les médicaments les contenant.
OA09419A (fr) Dérivés de l'acide 3-pyrrolidinylthio-1-azabicyclo (3.2.0.) -hept-2-ene-2-carboxylique et leur préparation.
FR2690159B1 (fr) Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant.
FR2717814B1 (fr) Dérivés de 1,2,4-triazolo(4,3-a)pyrazine-4-one, leur préparation et les médicaments les contenant.

Legal Events

Date Code Title Description
ST Notification of lapse